Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Microbiological Profile of Fracture Related Infection at a UK Major Trauma Centre
Kavi H Patel1, Laura I Gill2, Elizabeth K Tissingh1
1Limb Reconstruction and Bone Infection Service, The Royal London Hospital, Barts Health NHS Trust, Whitechapel Road, London E1 1FR, UK.
Abstract:
Fracture Related Infection (FRI) represents one of the biggest challenges for Trauma and Orthopaedic surgery. A better understanding of the microbiological profile should assist with decision-making and optimising outcomes. Our primary aim was to report on the microbiological profile of FRI cases treated over a six-year period at one of Europe's busiest trauma centres. Secondarily, we sought to correlate our findings with existing anti-microbiological protocols and report on diagnostic techniques employed in our practice. All adult cases of FRI treated in our institution between 2016 and 2021 were identified, retrospectively. We recorded patient demographics, diagnostic strategies, causative organisms and antibiotic susceptibilities. There were 330 infection episodes in 294 patients. A total of 463 potentially pathogenic organisms (78 different species) were identified from cultures, of which 57.2% were gram-positive and 39.7% gram-negative. Polymicrobial cultures were found in 33.6% of cases and no causative organism was found in 17.5%. The most prevalent organisms were Staphylococcus aureus (24.4%), coagulase-negative Staphylococci (14%), Pseudomonas aeruginosa (8.2%), Enterobacter species (7.8%) and Escherichia coli (6.9%). Resistant gram-positive organisms (methicillin resistant Staphylococcus aureus or vancomycin-resistant Enterococci) were implicated in 3.3% of infection episodes and resistant gram-negatives (extended-spectrum beta-lactamase, ampC or carbapenemase-producing bacteria) in 13.6%. The organisms cultured in 96.3% of infection episodes would have been covered by our empirical systemic antibiotic choice of teicoplanin and meropenem. To our knowledge, this is the largest reported single-centre cohort of FRIs from a major trauma centre. Our results demonstrate patterns in microbiological profiles that should serve to inform the decision-making process regarding antibiotic choices for both prophylaxis and treatment.
Insights
Fracture Related Infections (FRI) are a major surgical challenge. This study analyzed 330 FRI cases, identifying common bacteria like Staphylococcus aureus and Pseudomonas aeruginosa, to guide antibiotic treatment strategies.
Area of Science:
- Orthopaedic Surgery
- Infectious Diseases
- Microbiology
Background:
- Fracture Related Infection (FRI) poses significant challenges in Trauma and Orthopaedic surgery.
- Understanding the microbiological landscape of FRI is crucial for effective treatment and improved patient outcomes.
Purpose of the Study:
- To determine the microbiological profile of FRI cases treated over a six-year period.
- To correlate findings with current antibiotic protocols and diagnostic methods.
- To provide data from one of Europe's busiest trauma centers.
Main Methods:
- Retrospective analysis of adult FRI cases treated between 2016 and 2021.
- Collection of data on patient demographics, diagnostics, causative organisms, and antibiotic susceptibilities.
- Identification of 463 potentially pathogenic organisms from 330 infection episodes.
Main Results:
- The most common pathogens were Staphylococcus aureus (24.4%), coagulase-negative Staphylococci (14%), Pseudomonas aeruginosa (8.2%), Enterobacter species (7.8%), and Escherichia coli (6.9%).
- Polymicrobial infections occurred in 33.6% of cases; no organism was identified in 17.5%.
- Resistant organisms were found in 3.3% (gram-positive) and 13.6% (gram-negative) of episodes.
Conclusions:
- The identified microbiological patterns in FRI should inform empirical antibiotic choices for prophylaxis and treatment.
- The study provides the largest single-center cohort of FRIs from a major trauma center.
- Empirical antibiotic choices of teicoplanin and meropenem would cover 96.3% of cultured organisms.

